ID: ALA2393223

Max Phase: Preclinical

Molecular Formula: C10H9N3O

Molecular Weight: 187.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC(=O)c1ccc2c(N)ccnc2c1

Standard InChI:  InChI=1S/C10H9N3O/c11-8-3-4-13-9-5-6(10(12)14)1-2-7(8)9/h1-5H,(H2,11,13)(H2,12,14)

Standard InChI Key:  DRNOUAUANPKLON-UHFFFAOYSA-N

Associated Targets(non-human)

Ferriprotoporphyrin IX 165 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 187.20Molecular Weight (Monoisotopic): 187.0746AlogP: 0.92#Rotatable Bonds: 1
Polar Surface Area: 82.00Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.75CX LogP: 0.15CX LogD: 0.07
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.70Np Likeness Score: -0.83

References

1. Nsumiwa S, Kuter D, Wittlin S, Chibale K, Egan TJ..  (2013)  Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.,  21  (13): [PMID:23669191] [10.1016/j.bmc.2013.04.040]

Source